Smart Nanomaterials for Diagnosis and Therapy of Diseases
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (15 July 2022) | Viewed by 3437
Special Issue Editors
Interests: nanomedicine; nanotechnology; extracellular vesicles; zinc oxide; acoustic cavitation; ultrasound-assisted therapies; drug delivery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The use of nanomedicines, i.e., nanotechnology applied to medicine for diagnosis and treatment of different diseases, has attracted great interest in recent years, and not solely for cancer therapy.
Several nanosized materials have been widely investigated for this purpose, exploiting their intrinsic unique properties, although the exact mechanism of action is often subject to debate. Additionally, their activity has been optimized through the addition of different coatings, e.g., to improve chemical stability and stealth properties, or even the presence of targeting agents, which reduce off-targets while achieving powerful “smart” nanoplatforms for the early detection, treatment and possibly resolution of diseases.
This Special Issue aims to collect research or review articles that focus on the investigation of nanomaterials, e.g., nanoparticles, with particular emphasis on exploring the study of innovative solutions to enhance nanoparticle properties and develop new effective diagnostic, therapeutic or theranostic approaches with clear comprehension of the nanoparticle functioning mechanisms.
Prof. Dr. Valentina Cauda
Dr. Luisa Racca
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomaterials
- nanoparticles
- coatings
- targeting
- diagnosis
- therapy of diseases
- drug delivery
- theranostic
- cancer therapy
- infectious diseases.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
